Evaluation of the serum fasting insulin and HOMA-IR in diabetic and FDR patients

Background: Diabetes mellitus is an endocrine disorder. It is one of the leading causes of morbidity and mortality due to its role in the development of microvascular and macrovascular complications. The main pathophysiological features of type 2 diabetes mellitus are impaired insulin secretion and...

Full description

Saved in:
Bibliographic Details
Main Authors: Dipalee Rahul Navale, Vaishali Shashil Patil
Format: Article
Language:English
Published: Golestan University Of Medical Sciences 2024-12-01
Series:Journal of Clinical and Basic Research
Subjects:
Online Access:http://jcbr.goums.ac.ir/article-1-382-en.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: Diabetes mellitus is an endocrine disorder. It is one of the leading causes of morbidity and mortality due to its role in the development of microvascular and macrovascular complications. The main pathophysiological features of type 2 diabetes mellitus are impaired insulin secretion and increased insulin resistance (IR). There is a relationship between fasting serum insulin, IR, and beta-cell dysfunction. Familial aggregation is a significant risk factor for early-onset type 2 diabetes mellitus. First-degree relatives not only share genetic predispositions but also socio-environmental risk factors like obesity and hyperglycemia, forming a high-risk group. Methods: The study population consists of 60 people, including healthy controls (n = 20), first-degree relatives (n = 20), and diabetes patients (n = 20). The level of serum fasting insulin was measured by the chemiluminescence immunoassay method. IR was calculated using mathematical formulas such as HOMA-IR and HOMA-B. Results: The results showed that the level of serum insulin increased in the FDR group (8.5 ± 5.6) compared to the diabetic and control groups (p < 0.001). HOMA-IR was significantly increased in individuals with diabetes (2.10 ± 1.10) and the FDR group (1.81 ± 1.25) compared to controls (p < 0.0001). We also noted a strong positive correlation between fasting serum insulin and HOMA-IR in the FDR group (r = +0.98) and in diabetic patients (r = +0.79). Conclusion: Serum fasting insulin is an excellent and dependable marker for diagnosing IR in individuals at risk of developing diabetes, including FDR.
ISSN:2538-3736